Rhinomed Limited

ASX:RNO ISIN:AU000000RNO1

Rhinomed Limited ASX:RNO

Rhinomed Limited (ASX:RNO) is a Melbourne based technology firm with a focus on nasal, respiratory and breathing management technologies. The company is seeking to monetise applications of its technology portfolio in the Sport, Sleep, Wellbeing and Drug Delivery markets. For more information, go to www.rhinomed.global

TwitterFollow the Turbine on Twitter at @theturbinecom
Follow Mute Snoring on Twitter at @mutesnoring

       

Latest Headlines

Rhinomed Limited (ASX:RNO) Completes A$5.0 Million Capital Raise

🕔11/2/2018 10:19:59 AM

Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) a nasal delivery technology company has successfully undertaken a placement to institutional and sophisticated domestic and international investors at $0.21 per share. The company sought to raise a minimum of A$3.0 million and up to a maximum of A$5.0m and is pleased to report that demand saw the raise close at $A5.0 million.

Read Full Article

Rhinomed Limited (ASX:RNO) Business Update - FY19 Q1 September Quarterly Report

🕔10/31/2018 10:07:30 AM

Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) a leader in nasal delivery technology, today announced its 7th consecutive quarter on quarter of revenue growth. Positive trading conditions saw unaudited recognised revenues increase 30% over FY18 Q4 to $1.14m for FY19 Q1.

Read Full Article

Rhinomed Limited (ASX:RNO) Signs 12-Year Licensing Agreement with America's Largest Medical Cannabis Operator - Columbia Care LLC

🕔10/3/2018 8:30:39 AM

Melbourne based nasal respiratory company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to advise investors it has signed a 12-year exclusive licensing agreement of its nasal platform technology with Columbia Care LLC, the largest and most experienced provider of cannabis-based products and services in the United States (U.S.).

Read Full Article

Rhinomed Limited (ASX:RNO) and US Based Columbia Care LLC to Develop Nasally Delivered Dose Controlled Cannabis Based Medicines

🕔6/21/2018 11:20:00 AM

Melbourne based nasal respiratory company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to advise investors that it has signed a non-binding term sheet with Columbia Care LLC to license Rhinomed's nasal platform for the delivery of medical cannabis and cannabinoid compounds, analogues and derivatives.

Read Full Article

Rhinomed Ltd (ASX:RNO) Business Update - December Quarter

🕔1/30/2018 8:55:12 AM

Respiratory technology company Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) can report another strong quarter of growth. During the quarter the company shipped and invoiced $602k ($1.2m for the half year) worth of stock to retailers, consumers and distributors. This reflects the strength of the Company's growing global retail distribution base.

Read Full Article

Rhinomed Ltd (ASX:RNO) Completes AUD $3.6 Million Capital Raising

🕔11/29/2017 9:44:28 AM

Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) a leading sleep and nasal respiratory technology company has successfully undertaken an AUD$3.6 million placement to institutional and sophisticated private investors at $0.15 per share.

Read Full Article

Rhinomed Ltd (ASX:RNO) Investor Presentation October 2017

🕔10/5/2017 10:24:59 AM

Rhinomed Ltd (ASX:RNO) (OTCMKTS:RHNMF) provides the Company's latest Investor Presentation.

Read Full Article

Rhinomed Ltd (ASX:RNO) Preliminary Final Report

🕔8/28/2017 6:45:01 PM

The Directors of Rhinomed Limited ASX:RNO) provide the following Report in relation to the Group for the year ended 30 June 2017.

Read Full Article

Rhinomed Limited (ASX:RNO) Froome Wins 4th Tour De France Using Turbine

🕔7/25/2017 2:49:05 PM

A yellow nose ring matches the yellow jersey. Chris Froome, having taken his 4th Tour de France title continues to support yellow - in the form of an innovative sports breathing device called Turbine(TM).

Read Full Article

Rhinomed Ltd (ASX:RNO) Major Expansion of Mute USA Retail Footprint

🕔7/17/2017 9:55:16 AM

Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF), is pleased to announce that it has been advised that its sleep and breathing technology Mute, has been added to the annual 'large set' planogram produced by the Hamacher Resource Group, Inc.

Read Full Article

Rhinomed Ltd (ASX:RNO) May 2017 Investor Update - Delivering End to End Sleep Category Solutions

🕔5/16/2017 9:59:50 AM

Rhinomed Ltd (ASX:RNO) (OTCMKTS:RHNMF) are pleased to provide the Company's latest Investor Update for May 2017.

Read Full Article

Rhinomed Ltd (ASX:RNO) Amcal and Guardian Core Range Mute Australia Wide

🕔5/8/2017 10:11:03 AM

Respiratory technology company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to announce that it has been advised by Sigma Healthcare (ASX:SIG) that Mute sleep technology will form part of the 2017 core range for the Amcal and Guardian pharmacy brands.

Read Full Article

Rhinomed Ltd (ASX:RNO) Announce GNC USA (NYSE:GNC) to Sell Mute

🕔4/6/2017 10:03:47 AM

Respiratory technology company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to announce further expansion of its North American retail distribution footprint having received confirmation that its Mute sleep technology will go on sale in 811 GNC Holdings Inc. health, wellness and performance stores.

Read Full Article

Rhinomed Ltd (ASX:RNO) Adds US Based Cornerstone Investors and Initiates Capital Management Program

🕔3/15/2017 4:53:14 PM

Rhinomed (ASX:RNO) advises it has undertaken a AUD$2.19 million private placement to two US based sophisticated investor groups as part of its 15% placement capacity. In addition, the company has flagged its intention to hold a General Meeting to approve a capital management initiative that will seek to consolidate the company's capital and provide a sale of less than marketable share parcels facility.

Read Full Article

Rhinomed Ltd (ASX:RNO) Mute Global Distribution Milestone Update

🕔3/8/2017 12:18:23 PM

Rhinomed (ASX:RNO) is pleased to provide an update on the expansion of its global distribution program. The company can report that Rhinomed has been added as a vendor by two major US based pharmacy wholesalers and the successful expansion of the listing of its Mute Sleep technology by Symbion in Australia.

Read Full Article

Rhinomed Ltd (ASX:RNO) Quarterly Report

🕔10/30/2015 12:35:52 PM

Rhinomed (ASX:RNO) has had a strong first quarter of the financial year with positive traction across its consumer health and clinical businesses.

Read Full Article

Rhinomed Ltd (ASX:RNO) Annual Report to Shareholders

🕔9/30/2015 6:46:16 PM

Rhinomed Ltd (ASX:RNO) has launched two products into global markets during the financial year: launching our new sleep quality aid, Mute(TM) into the global sleep device market and a new generation Turbine(TM) sports product in response to feedback from users.

Read Full Article

Rhinomed Ltd (ASX:RNO) Raises $2.5m in Private Placement

🕔9/18/2015 10:05:57 AM

Rhinomed Limited (ASX:RNO) is pleased to announce today that it has raised a total of A$2.5m by a way of a placement of 78,125,000 fully paid ordinary shares at A$0.032 per shares with institutional, Sophisticated, and Offshore investors (placement).

Read Full Article

Rhinomed Ltd (ASX:RNO) Extends Mute Program Into SleepGP Network

🕔9/14/2015 3:01:11 PM

Australian respiratory technology company, Rhinomed (ASX:RNO) is pleased to announce it has entered into a landmark partnership with SleepGP, a growing network of GP practices, to raise awareness of sleep disordered breathing issues within the family medicine setting.

Read Full Article

Rhinomed Ltd (ASX:RNO) Rhinomed Newsletter September 2015

🕔9/4/2015 2:43:52 PM

Rhinomed Ltd (ASX:RNO) has been building its international presence and connections amongst the international investment and pharmaceutical community this year. In March, Michael Johnson was the keynote 'Rising Star' presentation at the Master Investor Show in London.

Read Full Article

Rhinomed Ltd (ASX:RNO) Production Capacity Upgrade

🕔8/28/2015 10:33:12 AM

Australian respiratory technology company Rhinomed Ltd (ASX:RNO) is pleased to advise it has increased its production line capacity at the ChinaMed production facility.

Read Full Article

Rhinomed Ltd (ASX:RNO) UK Pharmacy Distribution Secured for Mute

🕔8/21/2015 9:28:34 AM

Australian respiratory technology company Rhinomed Ltd (ASX:RNO), is pleased to announce its Mute snoring and sleep technology will be available on pharmacy shelves in the United Kingdom from late October 2015.

Read Full Article

Rhinomed Ltd (ASX:RNO) Rhinomed Quarterly Report

🕔7/31/2015 10:38:37 AM

Key highlights of the quarter included the growing demand for the company's new Turbine design and strong early demand for the Mute snoring and sleep technology. Receipts from Customers for the quarter were up $33k to $192k. Revenues from the Australian pharmacy channel will be included during the next quarter

Read Full Article

2013 Tour de France Yellow Jersey Winner Chris Froome Appointed as Rhinomed Ltd's (ASX:RNO) Turbine Ambassador

🕔7/6/2015 10:14:12 AM

Rhinomed Ltd (ASX:RNO) an Australian company focused on the development of novel nasal and respiratory technology today announced 2013 Tour de France Yellow Jersey winner Chris Froome has joined as its new Turbine(TM) Global Ambassador.

Read Full Article

Rhinomed Ltd (ASX:RNO) 2015 BIO International Convention Presentation

🕔6/18/2015 10:01:58 AM

Rhinomed Ltd (ASX:RNO) announce the 2015 BIO International Convention Presentation.

Read Full Article

Rhinomed Ltd (ASX:RNO) Sleep Apnea Trial of INPEAP Technology Receives Ethics Approval

🕔6/15/2015 10:14:49 AM

Rhinomed Ltd (ASX:RNO), an Australian company focused on the development of novel nasal and respiratory technologies, today announced that it has received Monash Health Human Research Ethics Committee (HREC) approval for its inaugural Phase 1 sleep apnea trial featuring its new Intranasal Positive Expiratory Airway Pressure (INPEAP) technology.

Read Full Article

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article

Rhinomed Ltd (ASX:RNO) To Present at World Leading Biotech Convention, 2015 BIO

🕔5/18/2015 10:06:45 AM

Rhinomed Ltd (ASX:RNO) is pleased to announce that it has been accepted as a presenter at 2015 BIO, the world's leading biotech convention to be held in Philadelphia, June 15-18th.

Read Full Article

Rhinomed Ltd (ASX:RNO) ResMed Inc to Sell Mute Snoring and Sleep Technology Online

🕔5/15/2015 9:20:54 AM

Australian respiratory technology company Rhinomed Ltd (ASX:RNO) has struck an important sales agreement with global sleep technology heavyweight ResMed Inc (NYSE:RMD) (ASX:RMD) to begin selling the novel Mute(TM) snoring reduction and sleep technology in the key UK market.

Read Full Article

Rhinomed Ltd (ASX:RNO) Mute Expands Wholesale Distribution

🕔4/30/2015 6:57:16 PM

Rhinomed (ASX:RNO) is pleased to announce it has continued to expand its Australian wholesale pharmacy distribution footprint with Sigma Pharmaceuticals Limited (ASX:SIP) to wholesale its Mute™ snoring and sleep quality technology.

Read Full Article

Rhinomed Ltd (ASX:RNO) Turbine Sales Recover and Mute Distribution Secured

🕔4/30/2015 6:48:42 PM

Rhinomed (ASX:RNO) is pleased to announce it has seen strong progress in the commercialisation of its nasal technology platform during FY15Q3.

Read Full Article

Rhinomed Ltd (ASX:RNO) Addresses 2015 UK Master Investor Show

🕔4/27/2015 8:26:28 AM

Rhinomed (ASX:RNO) presented the keynote address titled 'Changing the Way the World Breathes' at the 2015 Master Investor Show, held in London on 25th April 2015.

Read Full Article

Rhinomed Ltd (ASX:RNO) Shareholder Update

🕔4/9/2015 11:05:06 AM

Rhinomed Ltd (ASX:RNO) develops, markets and partners it's internal nasal technology platform into multiple form factors - internal nasal devices.

Read Full Article

Rhinomed (ASX:RNO) to initiate nation wide sleep study this Saturday night

🕔4/1/2015 11:15:35 AM

Rhinomed (ASX:RNO) a Melbourne based sleep and respiratory technology company is pleased to advise that it will initiate a nation wide sleep trial this Saturday night.

Read Full Article

Rhinomed Ltd (ASX:RNO) To Present at Master Investor UK Show

🕔3/31/2015 10:24:02 AM

Rhinomed (ASX:RNO) is pleased to advise CEO Michael Johnson has been invited to provide the keynote address on the Rising Stars Stage at the 2015 Master Investor Show (www.masterinvestor.co.uk) to be held in London on 25th April, 2015.

Read Full Article

Rhinomed Ltd (ASX:RNO) Mute Secures Australian Wholesale Pharmacy Distribution

🕔3/31/2015 9:51:12 AM

Rhinomed (ASX:RNO) is pleased to announce it has secured Australian wholesale pharmacy distribution with Symbion, part of the trans-Tasman EBOS Group, for its Mute(R) snoring and sleep quality technology.

Read Full Article

Rhinomed Ltd (ASX:RNO) Investor Newsletter

🕔3/19/2015 11:11:37 AM

Rhinomed Ltd (ASX:RNO) now has two products on the market. Having launched our first technology, Turbine(TM), into the Australian market for testing in January 2014, we have now released our new technology, Mute™ into the OTC snoring space.

Read Full Article

Rhinomed Ltd (ASX:RNO) Key US Appointment and Turbine Distribution Update

🕔3/4/2015 10:39:32 AM

The company has appointed Mr Christian Johnson as its Vice President, North America. Mr Johnson a seasoned sports industry executive was previously Vice President, Sales for GU Energy Labs, a high-growth, category leading, global sports nutrition brand.

Read Full Article

Rhinomed Ltd (ASX:RNO) Appendix 4D - Half Yearly Report and Accounts

🕔2/27/2015 4:13:25 PM

The first six months of the financial year saw Rhinomed Ltd (ASX:RNO) consolidate its move into the sport market with its inaugural technology, Turbine, which was launched in January 2014. Our strategy is to use Australia as a test market before taking our branded technology to global markets.

Read Full Article

Rhinomed Ltd (ASX:RNO) Appoints Justine Heath as New COO / CFO

🕔2/6/2015 8:27:28 AM

Rhinomed Ltd (ASX:RNO) is pleased to announce the appointment of Justine Heath as its Chief Operating Officer/Chief Financial Officer effective from today.

Read Full Article

Rhinomed Ltd (ASX:RNO) Quarterly Report

🕔1/30/2015 10:11:48 AM

Rhinomed Ltd (ASX:RNO) is encouraged by the strong level of interest in the technology platform from customers and partners both within Australian and overseas. The company is in a strong financial position to take full advantage of the technology platform that has been created over the last 18 months.

Read Full Article

Rhinomed Ltd (ASX:RNO) Release of Next Generation Turbine Sports Technology

🕔1/28/2015 1:29:37 PM

Rhinomed Ltd (ASX:RNO) is pleased to announce that it will begin shipping its next generation Turbine technology on February 9th, 2015.

Read Full Article

Rhinomed Ltd (ASX:RNO) CEO Presentation at Onemed Forum

🕔1/13/2015 10:16:59 AM

Rhinomed develops, markets and partners it's internal nasal technology platform into multiple form factors - internal nasal devices, with a focus on unmet needs in sport & exercise, sleep (snoring, sleep quality and sleep apnea), wellness and drug delivery

Read Full Article

Rhinomed Ltd (ASX:RNO) CEO to Present at Global Onemed Forum

🕔1/13/2015 9:15:11 AM

Melbourne technology firm, Rhinomed (ASX:RNO) today announced that CEO and Managing Director Mr. Michael Johnson will present a company update at the 8th Annual OneMed Forum on Monday, 12th January 2015 at 11.40 PST at the Marriott Marquis in San Francisco.

Read Full Article

Rhinomed Ltd (ASX:RNO) Australian Pharmacy Sales Force Appointed for Mute

🕔12/23/2014 5:23:59 PM

Melbourne technology firm, Rhinomed (ASX:RNO) is pleased to announce that it has appointed sales and marketing brokerage firm Brand Solutions Australia to represent Mute in the Australian Pharmacy and Grocery channel.

Read Full Article

Rhinomed Ltd (ASX:RNO) R&D Tax Incentive of $570k Received to Support Development

🕔12/22/2014 8:56:59 AM

Melbourne technology firm, Rhinomed (ASX:RNO) is pleased to announce that it has received a Research and Development tax refund of $570,337.

Read Full Article

Rhinomed Limited (ASX:RNO) Mute on Sale at www.mutesnoring.com

🕔12/8/2014 10:03:00 AM

Melbourne bio-technology firm, Rhinomed (ASX:RNO) is pleased to announce the release of its newest device from its nasal respiratory technology stable of products, Mute(TM), a nasal breathing aid to alleviate snoring and improve sleep quality.

Read Full Article

Rhinomed Limited (ASX:RNO) Mute Granted US FDA Registration

🕔12/3/2014 8:53:39 AM

Melbourne technology firm, Rhinomed (ASX:RNO) is pleased to announce that it has successfully completed the testing and technical documentation that has enabled its new novel snoring and sleep quality product - Mute(TM) to gain acceptance with the US Food and Drug Administration(FDA), European authority (CE Mark) and the Australian Therapeutic Goods Association (TGA).

Read Full Article

Rhinomed Limited's (ASX:RNO) Mute(TM) Successful in Demonstrating Efficacy and Benefit in Snoring Trial

🕔12/2/2014 2:39:58 PM

Melbourne technology firm, Rhinomed (ASX:RNO) today announced the topline results from its independent trial in snoring, sleep quality and night time nasal congestion which successfully demonstrated significant benefit of its new Mute nasal technology. The Company has submitted applications to the European, US and Australian regulatory authorities that will allow sale of the Mute technology to commence.

Read Full Article

Rhinomed Limited (ASX:RNO) Turbine Achieves CE Mark Registration

🕔11/11/2014 9:16:20 AM

Medical technology company Rhinomed Limited (ASX:RNO) is pleased to announce that it has successfully completed the testing and technical documentation that has enabled its sport technology the Turbine(TM) to receive the CE Mark.

Read Full Article

Rhinomed Limited (ASX:RNO) Releases Radical New Respiratory Sporting Technology

🕔11/22/2013 12:27:51 PM

Medical technology company Rhinomed, (ASX:RNO) has today released its inaugural product in the Australian market, the radical new respiratory sporting technology, the Turbine(TM).

Read Full Article

News

Rhinomed Limited (ASX:RNO) Completes A$5.0 Million Capital Raise

🕔11/2/2018 10:19:59 AM

Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) a nasal delivery technology company has successfully undertaken a placement to institutional and sophisticated domestic and international investors at $0.21 per share. The company sought to raise a minimum of A$3.0 million and up to a maximum of A$5.0m and is pleased to report that demand saw the raise close at $A5.0 million.

Read Full Article

Rhinomed Limited (ASX:RNO) Business Update - FY19 Q1 September Quarterly Report

🕔10/31/2018 10:07:30 AM

Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) a leader in nasal delivery technology, today announced its 7th consecutive quarter on quarter of revenue growth. Positive trading conditions saw unaudited recognised revenues increase 30% over FY18 Q4 to $1.14m for FY19 Q1.

Read Full Article

Rhinomed Limited (ASX:RNO) Signs 12-Year Licensing Agreement with America's Largest Medical Cannabis Operator - Columbia Care LLC

🕔10/3/2018 8:30:39 AM

Melbourne based nasal respiratory company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to advise investors it has signed a 12-year exclusive licensing agreement of its nasal platform technology with Columbia Care LLC, the largest and most experienced provider of cannabis-based products and services in the United States (U.S.).

Read Full Article

Rhinomed Limited (ASX:RNO) and US Based Columbia Care LLC to Develop Nasally Delivered Dose Controlled Cannabis Based Medicines

🕔6/21/2018 11:20:00 AM

Melbourne based nasal respiratory company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to advise investors that it has signed a non-binding term sheet with Columbia Care LLC to license Rhinomed's nasal platform for the delivery of medical cannabis and cannabinoid compounds, analogues and derivatives.

Read Full Article

Rhinomed Ltd (ASX:RNO) Business Update - December Quarter

🕔1/30/2018 8:55:12 AM

Respiratory technology company Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) can report another strong quarter of growth. During the quarter the company shipped and invoiced $602k ($1.2m for the half year) worth of stock to retailers, consumers and distributors. This reflects the strength of the Company's growing global retail distribution base.

Read Full Article

Rhinomed Ltd (ASX:RNO) Completes AUD $3.6 Million Capital Raising

🕔11/29/2017 9:44:28 AM

Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) a leading sleep and nasal respiratory technology company has successfully undertaken an AUD$3.6 million placement to institutional and sophisticated private investors at $0.15 per share.

Read Full Article

Rhinomed Ltd (ASX:RNO) Investor Presentation October 2017

🕔10/5/2017 10:24:59 AM

Rhinomed Ltd (ASX:RNO) (OTCMKTS:RHNMF) provides the Company's latest Investor Presentation.

Read Full Article

Rhinomed Ltd (ASX:RNO) Preliminary Final Report

🕔8/28/2017 6:45:01 PM

The Directors of Rhinomed Limited ASX:RNO) provide the following Report in relation to the Group for the year ended 30 June 2017.

Read Full Article

Rhinomed Limited (ASX:RNO) Froome Wins 4th Tour De France Using Turbine

🕔7/25/2017 2:49:05 PM

A yellow nose ring matches the yellow jersey. Chris Froome, having taken his 4th Tour de France title continues to support yellow - in the form of an innovative sports breathing device called Turbine(TM).

Read Full Article

Rhinomed Ltd (ASX:RNO) Major Expansion of Mute USA Retail Footprint

🕔7/17/2017 9:55:16 AM

Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF), is pleased to announce that it has been advised that its sleep and breathing technology Mute, has been added to the annual 'large set' planogram produced by the Hamacher Resource Group, Inc.

Read Full Article
###

26,403 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 98) (Last 30 Days: 414) (Since Published: 26403) 

Markets ASX:RNO

Company Data

    Headquarters
  • 97 Green St
    Cremorne
    Vic 3121
    Australia
  • Telephone
  • +61-3-8416-0900 
  • Fax
  • +61-3-8080-0796 
  • Principal Sector
  • Consumers 
  • Principal Industry
  • Medical Products 
  • Homepage
  • www.rhinomed.com.au
  • E:
  • mjohnson@rhinomed.com.au

Company Reports

Presentations

Quarterly Report

Social Media